| - SMTL ID
- 7eg2.1
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.2
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.3
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.4
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.5
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.6
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.7
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.8
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.9
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.10
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.11
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.12
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.13
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.14
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.15
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|
| - SMTL ID
- 7eg2.16
- Ligands
- (2~{S})-2-(hydroxymethyl)-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-4-(phenylmethyl)-3~{H}-inden-1-one
- Polypeptides
- Aequorin-2
- Oligo-state
- monomer
|